Last updated: July 11, 2026

Application No. 19/310,181

Untitled Application

Unknown

Filed

1600

Priority

Dec 18, 2020 — provisional 63/127,212 +2 more

Examiner

LIPPOLIS, ALEXANDRA ROSE

Art Unit

1637

Tech Center

YEDA RESEARCH AND DEVELOPMENT CO., LTD.

Assignee

Yeda Research and Development Co. Ltd.

OA Round

2 (Non-Final)

Interview Optional

— +65.0% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 38% grant rate with +65.0% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 24 resolved cases, 2023–2026

Examiner Intelligence

LIPPOLIS, ALEXANDRA ROSE View full profile →

Grants only 38% of cases

Career Allowance Rate

9 granted / 24 resolved

-22.5% vs TC avg

Strong +65% interview lift

Without

With

+65.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 9m

Avg Prosecution

45 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

2.7%

-37.3% vs TC avg

§103

68.9%

+28.9% vs TC avg

§102

7.7%

-32.3% vs TC avg

§112

6.8%

-33.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 24 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 24, 2026

Non-Final Rejection mailed

May 18, 2026

Response Filed

Jun 03, 2026

Final Rejection mailed

Jun 25, 2026

Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

17/428,506

Patent 12599637

A GENETICALLY MODIFIED LACTOBACILLUS AND USES THEREOF

4y 8m to grant Granted Apr 14, 2026

17/614,286

Patent 12600958

METHODS AND COMPOSITIONS FOR MANUFACTURING POLYNUCLEOTIDES

4y 4m to grant Granted Apr 14, 2026

17/132,511

Patent 12420073

Biosensor Tattoos and Uses Therefor for Biomarker Monitoring

4y 9m to grant Granted Sep 23, 2025

17/438,427

Patent 12410429

COMPOSITIONS AND METHODS FOR GENE TARGETING USING CRISPR-CAS AND TRANSPOSONS

3y 12m to grant Granted Sep 09, 2025

17/738,896

Patent 12378573

Asparaginase Based Selection System for Heterologous Protein Expression in Mammalian Cells

3y 3m to grant Granted Aug 05, 2025

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

38%

Grant Probability

99%

With Interview (+65.0%)

3y 9m

Median Time to Grant

Moderate

PTA Risk

Based on 24 resolved cases by this examiner. Grant probability derived from career allowance rate.